| Sheldon Weiner, MD | |
|
3577 W 13 Mile Rd, Suite 204, Royal Oak, MI 48073-6710 | |
| (248) 551-2441 | |
| (248) 551-1094 |
| Full Name | Sheldon Weiner |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology - Gynecologic Oncology |
| Location | 3577 W 13 Mile Rd, Royal Oak, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881654887 | NPI | - | NPPES |
| 700H273300 | Other | MI | BLUE SHIELD GROUP |
| 160F376970 | Other | MI | BLUE SHIELD INDIVIDUAL |
| 1881654887 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0201X | Obstetrics & Gynecology - Gynecologic Oncology | 4301039690 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sheldon Weiner, MD 29992 Northwestern Hwy, Suite C, Farmington Hills, MI 48334-3292 Ph: (248) 551-2446 | Sheldon Weiner, MD 3577 W 13 Mile Rd, Suite 204, Royal Oak, MI 48073-6710 Ph: (248) 551-2441 |
News Archive
HHS Secretary Tommy G. Thompson has announced the three states where Medicare will conduct a demonstration project involving a new definition for homebound that would allow Medicare beneficiaries receiving home health benefits to leave their home more frequently and for longer periods without risking the loss of those benefits.
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Ambrisentan Tablets, 5 mg and 10 mg.
Many states do not have the policy or environmental measures in place to help their residents meet the recommended levels of physical activity to promote health, according to a report released today by the Centers for Disease Control and Prevention.
better understand the impact sleep has on medical intern performance, researchers at BWH pioneered two studies both designed to underscore and support efforts hospitals can take to improve patient safety.
A team of scientists recently conducted a large-scale study at Northwell Health, New York, USA, to evaluate the efficacy of neutralizing monoclonal antibody (MAB) therapies in preventing disease progression among patients with mild to moderate COVID-19. The findings reveal that the timing of initiating MAB therapy is a crucial factor in determining its efficacy against COVID-19.
› Verified 3 days ago
Dr. Prabhleen Kaur Aneja, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-0845 | |
Theodoros Vlachos, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3535 W 13 Mile Rd Ste 329, Royal Oak, MI 48073 Phone: 248-551-1399 | |
Stefany Acosta-torres, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3577 W 13 Mile Rd Ste 302, Royal Oak, MI 48073 Phone: 248-551-1330 | |
Sonia Sajja, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-5000 | |
Stephanie Yuen Ting Wong, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3535 W 13 Mile Rd Ste 140, Royal Oak, MI 48073 Phone: 248-551-3000 | |
Paula M Fishbaugh, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 30701 Woodward Ave, Suite S200, Royal Oak, MI 48073 Phone: 248-584-7600 Fax: 248-584-7606 | |
Dr. Michael A Genord, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1103 N Main St, Suite E, Royal Oak, MI 48067 Phone: 248-399-7675 |